Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
adalimumab (humira) (2 trials)
azathioprine (imuran) (5 trials)
cyclosporine (sandimmune) (1 trial)
golimumab (simponi) (1 trial)
infliximab (remicade) (7 trials)
mercaptopurine (purinethol) (1 trial)
methotrexate (1 trial)
naltrexone (revia) (2 trials)
prednisone (meticorten) (1 trial)
thiopurine (1 trial)
urea (1 trial)
ustekinumab (stelara) (1 trial)
iron hydroxide dextran (1 trial)
mesalamine (rowasa) (1 trial)
Anemia (Phase 3)
Colitis (Phase 4)
Colitis, Ulcerative (Phase 4)
Crohn Disease (Phase 4)
Inflammatory Bowel Diseases (Phase 3)
Intestinal Diseases (Phase 3)
Recurrence (Phase 3)
Ulcer (Phase 4)
Trials (14 total)
Trial APIs (14 total)